Radiation Therapy Planning With Pet An Issue Of Pet Clinics

PET imaging has become an essential part of radiation therapy for cancer patients. Leading off the issue are articles on clinical applications and technical aspects. Following those are reviews of the use of PET in the treatment for lung cancer, gynecologic malignancies, GI and pancreatic tumors, and brain tumors, lymphoma, and head and neck malignancies. The final article addresses advances in hybrid imaging in planning of radiation therapy.

This issue of PET Clinics focuses on Evolving Role of PET in Assessing the Efficacy of Immunotherapy and Radiation Therapy in Malignant Disorders, and is edited by Drs. Charles B. Simone II, Nicolas Aide, and Abass Alavi (the Consulting Editor of PET Clinics). Articles will include: The Value of PET Imaging to Guide Target Delineation for Radiation Oncology; PET Imaging to Determine Radiation Dose, Adapt Radiation Plans, and Predict Patterns of Failure and Overall Survival for Non-small Cell Lung Cancer; The Utility of PET/CT for Radiation Oncology Planning, Surveillance, and Prognosis Prediction for Gastrointestinal Tumors; Evolving Role of PET Based Novel Quantitative Techniques to Detect Radiation-induced Complications; Current and Future PET Based Quantitative techniques to Assess Response to Radiation Therapy; Diagnosis, Staging, Radiation Treatment Response Assessment, and Prognostication; FDG PET/CT for Assessing Tumour Response to Immunotherapy and Detecting Immune-related Side Effects: A Checklist for the PET Reader; PET Imaging with Therapeutic Antibody-based PD-1/PD-L1 Checkpoint Tracers; FDG PET/CT for Assessing Tumour Response to Immunotherapy in Lymphomas; FDG PET/CT for Assessing Tumour Response to Immunotherapy in Solid Tumours: Melanoma and Beyond; and more!

PET imaging has become an essential part of radiation therapy for cancer patients. Leading off the issue are articles on clinical applications and technical aspects. Following those are reviews of the use of PET in the treatment for lung cancer, gynecologic malignancies, GI and pancreatic tumors, and brain tumors, lymphoma, and head and neck malignancies. The final article addresses advances in hybrid imaging in planning of radiation therapy.

Here is an exciting new guide to the use of PET-CT imaging in radiotherapy. You’ll get practical, useful information for utilizing this novel imaging technique—from different methods for contouring biological target volumes in various anatomic regions to how different experts use this imaging in targeted treatment. This thorough text helps you make concise, accurate treatment choices based on current evidence and expert authority. The result is an essential tool for everyone on the radiotherapy treatment team in the era of image-guided radiotherapy. Helps familiarize you with the basics of PET imaging in nuclear medicine. Covers the use of PET-CT with radiotherapy treatment planning, offering practical guidance in how different experts use this relatively new technology. Highlights contrast using full-color images, clearly indicating target volumes and different radiation dosages. Outlines the advantages and disadvantages of different techniques in contouring PET-CT target volumes for radiotherapy. Features case illustrations in using PET-CT in radiotherapy treatment planning for different tumor sites.

This issue, edited by Dr. Rakesh Kumar, reviews current clinical information in "PET Based Interventions." Articles will include: PET/CT in Radiofrequency Ablation; PET/CT Guided FNAC/Biopsy; PET/CT in Radiotherapy Planning; Dual Time Point Imaging; The Role of PET in Radiation Oncology; PET/CT in Individualization of Treatment (Personalized medicine); Ga68-DOTA-TOC PET/CT in targeted radionuclide therapy (Lu188 therapy for NET); Role of FDG PET/CT in Targeted Radionuclide Therapy of Endocrine Malignancies; Overview of Conventional Imaging Based Intervention in Clinical Practice; Special Techniques in PET/CT in Evaluating Genito-urinary Malignancies; and more!

This issue of PET Clinics focuses on Lung Cancer, and is edited by Drs. Gang Cheng and Timothy Akhurst. Articles will include: FDG PET/CT for lung cancer staging; Lung neoplasms with low FDG avidity; FDG PET/CT evaluation of lung cancer in populations with high prevalence of granulomatous disease; Prognostic value of FDG PET/CT; Genomic characterization of lung cancer and its impact on the use and timing of PET in therapeutic response assessment; Treatment planning for radiation therapy; Future directions of PET imaging for lung cancer; PET for RT-planning in lung cancer; Genomic characterization of lung cancer and its impact on the use and timing of PET in therapeutic response assessment; and more!

This issue discusses the newest approaches to PET/CT Imaging. The roles of PET/CT in pulmonary masses, GI malignancies, head and neck cancer, lymphoma, soft tissue sarcoma, pancreatic and biliary tree malignancies, malignant melanoma, breast carcinoma, common pediatric malignancies, bone malignancies, and the role PET/CT plays in radiation oncology treatment planning are reviewed.

This issue of PET Clinics focuses on Evolving Role of PET-guided Interventional Oncology Based Procedures, and is edited by Drs. Abass Alavi (the Consulting Editor of PET Clinics), Marnix Lam, Stephen Hunt, and Ghassan El-Haddad. Articles will include: Y-90 PET/CT and radioembolization; FDG-PET and radioembolization; Ga-68-PSMA PET and HCC; C11 Acetate-PET for hepatocellular carcinoma patients undergoing radioembolization; FDG-PET for Ablation Treatment Planning, Intraprocedural Monitoring and Response; Global FDG Response Assessment to IR Procedures with Concomitant Immunotherapy; PET Assessment of Abscopal Effects and Pseudoprogression from IR Procedures; FDG-PET for monitoring response to embolotherapy (TACE) in primary and metastatic liver disease; and more!